Literature DB >> 9707310

Genetic determinants of Pseudomonas aeruginosa colonization in cystic fibrosis patients in Canada.

M De Braekeleer1, C Allard, J P Leblanc, G Aubin, F Simard.   

Abstract

The present study was aimed at analyzing whether the rate of colonization and the age at colonization with Pseudomonas aeruginosa was genetically determined in cystic fibrosis (CF) patients. These two variables were calculated among 127 CF patients whose genotypes were known and who were monitored at the Clinique de Fibrose Kystique in Saguenay Lac-Saint-Jean. No statistically significant differences were found in the rate or the age at colonization when the patients were grouped by genotype; however, this result could be due to the small number of patients in each genotype group. The rate of colonization was significantly lower among CF patients carrying the A455E mutation, a "mild" allele with respect to exocrine pancreatic function, than among those carrying either the deltaF508 or the 621 + IG- > T mutation, both of which are "severe" alleles. The results confirm previous reports that the rate of colonization with Pseudomonas aeruginosa is, at least in part, genetically determined.

Entities:  

Mesh:

Year:  1998        PMID: 9707310     DOI: 10.1007/bf01699984

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  14 in total

1.  Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa.

Authors:  E Kerem; M Corey; R Gold; H Levison
Journal:  J Pediatr       Date:  1990-05       Impact factor: 4.406

2.  How mutant CFTR may contribute to Pseudomonas aeruginosa infection in cystic fibrosis.

Authors:  G B Pier; M Grout; T S Zaidi; J B Goldberg
Journal:  Am J Respir Crit Care Med       Date:  1996-10       Impact factor: 21.405

3.  Genotype-phenotype correlation in cystic fibrosis patients compound heterozygous for the A455E mutation.

Authors:  M De Braekeleer; C Allard; J P Leblanc; F Simard; G Aubin
Journal:  Hum Genet       Date:  1997-12       Impact factor: 4.132

4.  Correlation between genotype and phenotype in patients with cystic fibrosis.

Authors: 
Journal:  N Engl J Med       Date:  1993-10-28       Impact factor: 91.245

5.  Genetic determination of exocrine pancreatic function in cystic fibrosis.

Authors:  P Kristidis; D Bozon; M Corey; D Markiewicz; J Rommens; L C Tsui; P Durie
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

6.  Genetic epidemiology of cystic fibrosis in Saguenay-Lac-St-Jean (Quebec, Canada).

Authors:  J Daigneault; G Aubin; F Simard; M De Braekeleer
Journal:  Clin Genet       Date:  1991-10       Impact factor: 4.438

7.  Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections.

Authors:  G B Pier; M Grout; T S Zaidi; J C Olsen; L G Johnson; J R Yankaskas; J B Goldberg
Journal:  Science       Date:  1996-01-05       Impact factor: 47.728

8.  Binding of Pseudomonas aeruginosa to respiratory epithelial cells from patients with various mutations in the cystic fibrosis transmembrane regulator.

Authors:  H Zar; L Saiman; L Quittell; A Prince
Journal:  J Pediatr       Date:  1995-02       Impact factor: 4.406

9.  Genetic determinants of airways' colonisation with Pseudomonas aeruginosa in cystic fibrosis.

Authors:  P Kubesch; T Dörk; U Wulbrand; N Kälin; T Neumann; B Wulf; H Geerlings; H Weissbrodt; H von der Hardt; B Tümmler
Journal:  Lancet       Date:  1993-01-23       Impact factor: 79.321

10.  Prognostic implications of initial oropharyngeal bacterial flora in patients with cystic fibrosis diagnosed before the age of two years.

Authors:  V L Hudson; C L Wielinski; W E Regelmann
Journal:  J Pediatr       Date:  1993-06       Impact factor: 4.406

View more
  1 in total

1.  Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort.

Authors:  Margaret Rosenfeld; Julia Emerson; Sharon McNamara; Valeria Thompson; Bonnie W Ramsey; Wayne Morgan; Ronald L Gibson
Journal:  J Cyst Fibros       Date:  2012-05-01       Impact factor: 5.482

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.